The FDA requires a risk evaluation and mitigation strategy for phentermine/topiramate to ensure the benefits outweigh the risks and that patients of reproductive age are informed about the dangers of taking this medication during the first trimester
Joshua D Rosenblat has received research grant support from the Canadian Institute of Health Research (CIHR), Physician Services Inc (PSI) Foundation, Labatt Brain Health Network, Brain and Cognition Discovery Foundation (BCDF), Canadian Cancer Society, Canadian Psychiatric Association, Academic Scholars Award, American Psychiatric Association, American Society of Psychopharmacology, University of Toronto, University Health Network Centre for Mental Health, Joseph M
When combined with healthy lifestyle changes, GLP-1 medications can help people achieve steady, long-term weight loss
doi:10.1007/978-3-030-28929-4_3